SecBot SecBot
SECBOTREPLAY Home › Report › AZN

AZN · The U.S

ASTRAZENECA PLC · COURT-RULING filed Aug 17, 2026 at 20:00 ET

At the news

NEUTRALIMPACT 1/10

COURT-RULING filed Aug 17, 2026 at 20:00 ET

The U.S. District Court for the District of Maryland denied plaintiff Monique Richards Smith's motion to alter or amend judgment in an ADA discrimination and retaliation suit against AstraZeneca Pharmaceuticals LP. The court had previously granted summary judgment to AstraZeneca, and the denial of this post-judgment motion confirms that the case remains closed with no liability for the company.

  • The Court granted AstraZeneca's motion for summary judgment on all ADA claims on March 17, 2026.
  • Plaintiff's motion to alter or amend judgment (Rule 59(e)) was denied on August 18, 2026.
  • The case involves a single former employee's individual claims, no class action, no material financial exposure, and no business impact.
  • AstraZeneca's market cap is ~$248.3B, making any potential damages in this routine employment case immaterial.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access